Publications by authors named "Gitte F Persson"

Claim this Profile
P
Predictors of acute and late diarrhea in the treatment of anal cancer with concurrent chemoradiotherapy.
Katrine Smedegaard Storm, Karen-Lise Garm Spindler, Gitte Fredberg Persson, Claus Behrens, Patrik Sibolt

Acta Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and pre-trial dose planning quality assurance of the Nordic trial of inhomogeneous dose escalated radiotherapy for patients with limited disease small cell lung cancer: NIELS.
Sara Linde, Ditte S Møller, Mai-Britt Linaa, Ane Appelt, Erik Almhagen, Gitte F Persson

Radiother Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to "Optimizing radiotherapy for anal cancer: A call for sub-structure based dose constraints".
Katrine S Storm, Karen Lise G Spindler, Gitte F Persson, Camilla Kronborg, Eva Serup-Hansen

Radiother Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Ablative Radiation Therapy of Bone Metastases in an Oligometastatic Setting: One-Year Follow-Up of the BONY-M Phase 2 Trial.
Nicklas Juel Spindler, Mette van Overeem Felter, Olfred Hansen, Tine Bjørn Nielsen, Morten Hiul Suppli, Gitte Fredberg Persson

Int J Radiat Oncol Biol Phys· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote Symptom Monitoring of Patients With Advanced Lung Cancer (The ProWide Study): A Randomized Controlled Trial.
Rasmus Blechingberg Friis, Helle Pappot, Niels Henrik Hjollund, Tine McCulloch, Marianne Ingerslev Holt, Gitte Fredberg Persson

JCO Oncol Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiation therapy (SBRT) of centrally located medically inoperable early-stage non-small cell lung cancer (T1-T3N0M0) - A subgroup analysis of the expanded HILUS study.
Sara Lindberg, Vitali Grozman, Kristin Karlsson, Eva Onjukka, Elias Lindbäck, Gitte Fredberg Persson

Lung Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-year efficacy results after MR-guided risk-adapted stereotactic radiotherapy of infra-diaphragmatic oligometastases in a multicenter phase II trial.
Mette van Overeem Felter, Pia Krause Møller, Mirjana Josipovic, Susanne Nørring Bekke, Uffe Bernchou, Gitte Fredberg Persson

Radiother Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower urinary tract sub-structures as predictors of late urinary toxicity in concurrent chemo-radiotherapy for anal cancer.
Katrine S Storm, Karen Lise G Spindler, Gitte F Persson, Camilla Kronborg, Eva Serup-Hansen

Radiother Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study.
Agon Olloni, Carsten Brink, Ebbe Laugaard Lorenzen, Stefan Starup Jeppesen, Lone Hofmann, Gitte Fredberg Persson

JTO Clin Res Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MR-guided stereotactic radiotherapy of infra-diaphragmatic oligometastases: Evaluation of toxicity and dosimetric parameters.
Mette van Overeem Felter, Pia Krause Møller, Mirjana Josipovic, Susanne Nørring Bekke, Uffe Bernchou, Gitte Fredberg Persson

Radiother Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROAR-A: re-optimization based Online Adaptive Radiotherapy of anal cancer, a prospective phase II trial protocol.
Katrine Smedegaard Storm, Lina M Åström, Patrik Sibolt, Claus P Behrens, Gitte F Persson

BMC Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.
Sara Lindberg, Vitali Grozman, Kristin Karlsson, Eva Onjukka, Elias Lindbäck, Gitte Fredberg Persson

Int J Radiat Oncol Biol Phys· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim analysis of patient-reported outcome compliance and dosimetry in a phase 3 randomized clinical trial of oesophagus-sparing spinal radiotherapy.
Anna Mann Nielsen, Katrine Smedegaard Storm, Michael R T Laursen, Vanja Remberg Gram, Laura Ann Rechner, Gitte F Persson

Acta Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential for local ablative therapy of oligometastases in head and neck squamous cell carcinoma: a real-world data analysis.
Julie Kjems, Michael R T Laursen, Claus A Kristensen, Anita B Gothelf, Mogens Bernsdorf, Gitte F Persson

Acta Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does coronary artery calcium score have an impact on overall survival for locally advanced non-small cell lung cancer treated with definitive radiotherapy.
Agon Olloni, Carsten Brink, Ebbe L Lorenzen, Stefan S Jeppesen, Lone Hoffmann, Gitte F Persson

Radiother Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised phase II trial of stereotactic body radiotherapy in combination with point inhibitors in metastatic castration-resistant state cancer (CheckPRO): a study protocol.
Nicklas Juel Spindler, Gitte Fredberg Persson, Susann Theile, Dorte Lisbeth Nielsen, Estrid V Høgdall

BMJ Open· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of oesophageal toxicity with VMAT dose-sparing radiotherapy in thoracic metastatic spinal cord compression: A feasibility study.
Vanja Remberg Gram, Daniel Gram, Gitte Fredberg Persson, Morten Hiul Suppli, Sarah Barrett

Tech Innov Patient Support Radiat Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualizing the Oncological Treatment of Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma by Using Gene Sequencing and Patient-Reported Outcomes: Protocol for the INDIGO Study.
Ida Marie Lind Rasmussen, Anne Vest Soerensen, Anne Kirstine Møller, Gitte Fredberg Persson, Jesper Andreas Palshof

JMIR Res Protoc· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data on melanoma brain metastases and survival outcome.
Sidsel Pedersen, Søren Møller, Marco Donia, Gitte Fredberg Persson, Inge Marie Svane

Melanoma Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic 4DCT(MRI) lung phantom generation for 4D radiotherapy and image guidance investigations.
Alisha Duetschler, Grzegorz Bauman, Oliver Bieri, Philippe C Cattin, Stefanie Ehrbar, Gitte F Persson

Med Phys· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study.
Mette T Mouritzen, Karen F Junker, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Gitte F Persson

Acta Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Intensity Aerobic exercise training and Immune cell Mobilization in patients with lung cancer (HI AIM)-a randomized controlled trial.
Gitte Holmen Olofsson, Marta Kramer Mikkelsen, Anne-Mette Ragle, Anne Birgitte Christiansen, Anne Pries Olsen, Gitte Fredberg Persson

BMC Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forecasting lung cancer incidence, mortality, and prevalence to year 2030.
Erik Jakobsen, Karen Ege Olsen, Mette Bliddal, Malene Hornbak, Gitte F Persson

BMC Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy.
Mette T Mouritzen, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders W M Nielsen, Gitte F Persson

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy.
Karin Lindberg, Vitali Grozman, Kristin Karlsson, Sara Lindberg, Ingmar Lax, Gitte Fredberg Persson

J Thorac Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis